Testing effectiveness (Phase 2)WithdrawnNCT04665115
What this trial is testing
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
Who this might be right for
Asymptomatic COVID-19 Infection Laboratory-ConfirmedB-Cell NeoplasmChronic Lymphocytic Leukemia+6 more
Academic and Community Cancer Research United